The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…
An investment of seven million Euros. A new site of 5 thousand new square metres, more than half to be used for production. And a doubling - from today’s 42 to 80 - of the workforce…